↓ Skip to main content

Long-term survival without graft-versus-host-disease following infusion of allogeneic myeloma-specific Vβ T cell families

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2019
Altmetric Badge

Mentioned by

twitter
3 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Long-term survival without graft-versus-host-disease following infusion of allogeneic myeloma-specific Vβ T cell families
Published in
Journal for Immunotherapy of Cancer, November 2019
DOI 10.1186/s40425-019-0776-9
Pubmed ID
Authors

S. Yado, G. Luboshits, O. Hazan, R. Or, M. A. Firer

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 13%
Other 2 13%
Student > Ph. D. Student 2 13%
Lecturer > Senior Lecturer 1 6%
Student > Bachelor 1 6%
Other 4 25%
Unknown 4 25%
Readers by discipline Count As %
Immunology and Microbiology 3 19%
Medicine and Dentistry 2 13%
Unspecified 1 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Biochemistry, Genetics and Molecular Biology 1 6%
Other 3 19%
Unknown 5 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 December 2019.
All research outputs
#17,408,360
of 25,540,105 outputs
Outputs from Journal for Immunotherapy of Cancer
#2,910
of 3,454 outputs
Outputs of similar age
#239,023
of 375,539 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#84
of 95 outputs
Altmetric has tracked 25,540,105 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,454 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.7. This one is in the 12th percentile – i.e., 12% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 375,539 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 95 others from the same source and published within six weeks on either side of this one. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.